Clinical Trial: Administration of Oral Probiotic Streptococcus Salivarius K12

U.S., Aug. 12 -- ClinicalTrials.gov registry received information related to the study (NCT07757360) titled 'Administration of Oral Probiotic Streptococcus Salivarius K12' on June 10.

Brief Summary: The clinical trial is investigating the oral administration of probiotic Streptococcus salivarius K12 in the form of lozenges in healthy adults.

The main outcome measures are:

* Potential for Streptococcus salivarius K12 to colonise the oral cavity

* Effect on other bacteria and Candida albicans in the oral cavity

* Possible anti-inflammatory effect

Participants will:

* Take one lozenge containing Streptococcus salivarius K12 daily for 4 weeks

* Attend 3 dental check-ups (before starting the probiotic treatment, and after 4 and 8 weeks)...